Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetomo Himuro

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Kurume Medical Journal|May 22, 2018
The Effect of Ozone on Colonic Epithelial CellsHidetomo Himuro
Journal of Translational Medicine|May 23, 2022
Exhaustion of CAR T cells: potential causes and solutionsTaku Kouro, Hidetomo Himuro, Tetsuro Sasada
The Journal of Pathology|September 22, 2015
Genetically engineered mouse models for studying inflammatory bowel diseaseAtsushi Mizoguchi, Takahito Takeuchi, Hidetomo Himuro, et al.
Journal of Gastroenterology|October 28, 2017
Clinical importance of IL-22 cascade in IBDAtsushi Mizoguchi, Arisa Yano, Hidetomo Himuro, et al.
Frontiers in Immunology|May 1, 2025
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequenceTaku Kouro, Daisuke Hoshino, Yasunobu Mano, et al.
Japanese Journal of Radiology|May 2, 2020
Imaging features in patients with SAPHO/CRMO: a pictorial reviewHidetomo Himuro, Seiji Kurata, Shuji Nagata, et al.
Biomedicines|June 27, 2024
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid CancerKazumasa Sekihara, Hidetomo Himuro, Soji Toda, et al.
Cancer Cell International|December 10, 2022
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D culturesKazumasa Sekihara, Hidetomo Himuro, Nao Saito, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2021
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibodyYoshiro Nakahara, Takaji Matsutani, Yuka Igarashi, et al.
Frontiers in Pharmacology|November 29, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinomaYosuke Shibata, Takeshi Kishida, Taku Kouro, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Kurume Medical Journal|May 22, 2018
The Effect of Ozone on Colonic Epithelial CellsHidetomo Himuro
Journal of Translational Medicine|May 23, 2022
Exhaustion of CAR T cells: potential causes and solutionsTaku Kouro, Hidetomo Himuro, Tetsuro Sasada
The Journal of Pathology|September 22, 2015
Genetically engineered mouse models for studying inflammatory bowel diseaseAtsushi Mizoguchi, Takahito Takeuchi, Hidetomo Himuro, et al.
Journal of Gastroenterology|October 28, 2017
Clinical importance of IL-22 cascade in IBDAtsushi Mizoguchi, Arisa Yano, Hidetomo Himuro, et al.
Frontiers in Immunology|May 1, 2025
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequenceTaku Kouro, Daisuke Hoshino, Yasunobu Mano, et al.
Japanese Journal of Radiology|May 2, 2020
Imaging features in patients with SAPHO/CRMO: a pictorial reviewHidetomo Himuro, Seiji Kurata, Shuji Nagata, et al.
Biomedicines|June 27, 2024
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid CancerKazumasa Sekihara, Hidetomo Himuro, Soji Toda, et al.
Cancer Cell International|December 10, 2022
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D culturesKazumasa Sekihara, Hidetomo Himuro, Nao Saito, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2021
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibodyYoshiro Nakahara, Takaji Matsutani, Yuka Igarashi, et al.
Frontiers in Pharmacology|November 29, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinomaYosuke Shibata, Takeshi Kishida, Taku Kouro, et al.
Pageof 2